PEX168(100µg)
Sponsors
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Conditions
Type 2 Diabetes Mellitus
Phase 3
Efficacy and Safety Study of PEX168 in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin
NCT02477969
Start: 2014-02-27End: 2017-06-30Updated: 2017-01-24
Efficacy and Safety Study of PEX168 in Monotherapy Diabetes Mellitus Type 2 Patients
NCT02477865
Start: 2014-03-23End: 2017-02-28Updated: 2017-01-24